Hasta La Creative!

A year after they were accused of misleading advertising practices, Pfizer is set to resume it advertising prowess with a twist; no celebrities, no expert advice. A wise move? Well perhaps considering that the best way to market is through the testimony of actual people who have tried it can be cheaper and more effective.

But basing from its run-in last year, it looks like Pfizer has a lot of work to do on the part of once again getting the trust of the public. Well, they have to start somewhere and apparently this is a good way to do it without any strings attached this time around.

This time around, Pfizer felt that using an average guy, someone with a story similar to that of many other baby boomers, struck the right chord.

“When we did testing with consumers, what we found out was John really resonated with them,” said Jim Sage, senior director and leader of the Lipitor marketing team at Pfizer.

Mr. Sage declined to say how much the drug company is spending on the new campaign but said it will have a wide presence on TV and in print. “This ad is going to run for a while on a national basis,” he said.

(Source) The Wall Street Journal

Brian Yalung is a Problogger at Talent Zoo mainly contributing to latest news and issues on advertising and marketing. The sites are as follows: www.beyondmadisonavenue.com, Talent Zoo is the #1 site for Ad, Marketing, and Media Professionals. Catch the Buzz at Beyond Madison Avenue!